Holen Sie sich die Stockscreener-App
526.43
1.86%
10.88
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt VRTX?
Forum
Prognose
Aktiensplit
Vertex Pharmaceuticals Inc Aktie (VRTX) Neueste Nachrichten
UNIVEST FINANCIAL Corp Takes Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Perigon Wealth Management LLC Takes $4.39 Million Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Acquires New Shares in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Citizens Financial Group Inc. RI Purchases New Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Cornerstone Advisors LLC Purchases New Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
6,857 Shares in Vertex Pharmaceuticals Incorporated $VRTX Bought by Commerzbank Aktiengesellschaft FI - MarketBeat
Deutsche Bank AG Invests $784.39 Million in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
BlackRock Inc. Invests $11.98 Billion in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
2,792 Shares in Vertex Pharmaceuticals Incorporated $VRTX Purchased by Simplicity Wealth LLC - MarketBeat
Plato Investment Management Ltd Purchases Shares of 6,083 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Nippon Life Global Investors Americas Inc. Makes New $18.99 Million Investment in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Flputnam Investment Management Co. Invests $19.93 Million in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
2,486,038 Shares in Vertex Pharmaceuticals Incorporated $VRTX Bought by AIGH Capital Management LLC - MarketBeat
TFR Capital LLC. Takes Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
125,970 Shares in Vertex Pharmaceuticals Incorporated $VRTX Bought by ABN AMRO Bank N.V. - MarketBeat
Vertex Pharmaceuticals (NASDAQ:VRTX) stock in focus as gene therapy sales climb - Kalkine Media
Summit Global Investments Acquires Shares of 7,182 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Trifecta Capital Advisors LLC Purchases New Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Oppenheimer Asset Management Inc. Makes New Investment in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough? - Yahoo Finance
Is Vertex Pharmaceuticals (VRTX) Fairly Valued As Pipeline Catalysts Near? - Yahoo Finance
Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More - The Motley Fool
Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
Vertex Pharmaceuticals (VRTX) Could Be 8% Undervalued Following Raised 2026 Guidance - Yahoo Finance
Vertex-Crinetics pharma merger cleared in US, Germany, Austria, Australia - mlex.com
$100 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth This Much Today - Benzinga
Vertex Pharmaceuticals: I Was Wrong About Its Near-Term Prospects (Rating Upgrade) - Seeking Alpha
Crinetics Pharmaceuticals merger with Vertex Pharmaceuticals advances after regulatory clearances - Investing.com
Crinetics Pharmaceuticals (CRNX) advances Vertex merger after key antitrust milestones - Stock Titan
Vertex Pharmaceuticals Inc (VRTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Vertex Pharmaceuticals (VRTX) Q1 2026 Earnings Call Transcript - Fortune
Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says - marketscreener.com
Jefferies Remains a Buy on Vertex Pharmaceuticals (VRTX) - The Globe and Mail
RBC Capital reiterates Vertex stock rating on pipeline outlook By Investing.com - Investing.com Canada
Scotiabank Remains a Buy on Vertex Pharmaceuticals (VRTX) - The Globe and Mail
Analysts Conflicted on These Healthcare Names: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX) and Agios Pharma (AGIO) - The Globe and Mail
A Quick Look at Today's Ratings for Vertex Pharmaceuticals(VRTX.US), With a Forecast Between $558 to $633 - Moomoo
Fierce Biotech Layoff Tracker 2026: Aura loses 20% of staffers; aTyr shrinks by 60% - Fierce Biotech
5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings Call - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and MoonLake Immunotherapeutics (MLTX) - The Globe and Mail
Bernstein reiterates Vertex stock rating on cystic fibrosis outlook By Investing.com - Investing.com Canada
Bernstein reiterates Vertex stock rating on cystic fibrosis outlook - Investing.com
4 Biotech Stocks With Major Second-Half Pipeline Catalysts This Year - Yahoo Finance
Vertex Pharma stock added to BofA US 1 list of top ideas - Investing.com Nigeria
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Handelsbanken Fonder AB - MarketBeat
Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $633 From $610, Maintains Buy Rating - marketscreener.com
Vertex Pharmaceuticals Faces New Competitive Threats - Intellectia AI
VERTEX PHARMACEUTICALS INCORPORATED : JEFFERIES RAISES TARGET PRICE TO $633 FROM $610 - Bitget
Vertex Pharmaceuticals Inc. Stock Rises 5.6%, Outperforms Peers - webull.com
Why Vertex Pharma Popped, As A Key Rival Plummeted 92% - Investor's Business Daily
Wolfe Research raises Vertex stock price target on CF franchise value - Investing.com
Wall Street Analysts Are Neutral on Top Healthcare Picks - theglobeandmail.com
Sionna cystic fibrosis drug fails key trial, removing threat to Vertex - BioPharma Dive
Vertex's would-be rival Sionna scraps cystic fibrosis drug add-on after trial flop - FirstWord PHARMA
Vertex Stock (VRTX) Soars 7% as Rival Sionna (SION) Crashes 92% on Failed Drug Trial - TipRanks
Vertex Stock Jumps 5.9% as Rival Cystic Fibrosis Drug Fails - TradingView
Sionna’s experimental cystic fibrosis pill falls flat in mid-stage trial - STAT
Vertex Pharmaceuticals (VRTX) Is Up 5.4% After Raising 2026 Revenue Guidance And Expanding Its PipelineHas The Bull Case Changed? - Yahoo Finance
Vertex Pharmaceuticals (NASDAQ:VRTX) Hits New 52-Week HighStill a Buy? - MarketBeat
Why is Vertex Pharmaceuticals stock surging today? By Investing.com - Investing.com South Africa
Vertex Pharmaceuticals stock hits all-time high at 539.99 USD By Investing.com - Investing.com Australia
Vertex Pharmaceuticals Inc Stock (VRTX) Opened Up by 9.76% on Aug 10: What Investors Need To Know - TradingKey
Sionna’s cystic fibrosis flop sends stock down 90%, but a ‘significant positive’ for Vertex - Fierce Biotech
Vertex Pharmaceuticals stock hits all-time high at 539.99 USD - Investing.com
0.65%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):